Nanexa

Nanexa Intangible Assets

The Intangible Assets of Nanexa (NANEXA.ST) as of Oct 23, 2026 is 59.40 M SEK. In the previous year, Intangible Assets was 40.48 M SEK — a change of 46.75% (higher).

Intangible Assets

59.40 MSEK

YoY

46.75%

Last updated:

Intangible Assets of Nanexa is 2024 59.40 M SEK. Intangible Assets of Nanexa was 2023 40.48 M SEK. It decreases by 46.75% higher compared to the previous year.

The Nanexa Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2018
11.00 M SEK
Jan 1, 2019
17.00 M SEK
Jan 1, 2020
33.50 M SEK
Jan 1, 2021
45.70 M SEK
Jan 1, 2022
65.25 M SEK
Jan 1, 2023
40.48 M SEK
Jan 1, 2024
59.40 M SEK
The Nanexa Intangible Assets history
YEARIntangible AssetsYoY
59.40 MSEK+46.75%
40.48 MSEK-37.97%
65.25 MSEK+42.77%
45.70 MSEK+36.42%
33.50 MSEK+97.06%
17.00 MSEK+54.55%
11.00 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanexa Stock analysis

What does Nanexa do? Nanexa AB develops and distributes medical nanotechnology products including PharmaShell, a drug delivery system for targeted dosing, and antifungal coating that protects medical products from fungal growth. The company also offers low-friction coating for peripheral venous catheters. Its products are sold to healthcare providers and medical device manufacturers seeking advanced solutions for drug delivery and infection prevention. Nanexa AB's revenue comes from the sale of its nanotechnology-based products to healthcare institutions and medical device companies. The firm focuses on life science R&D, targeting applications in pharmaceuticals and medical device manufacturing. Its product portfolio serves the healthcare sector by enhancing drug efficacy and protecting medical equipment from microbial contamination. The company's business model relies on selling specialized coatings and delivery systems to medical professionals and manufacturers. PharmaShell enables precise drug targeting, while antifungal and low-friction coatings address specific clinical needs in medical device usage. These products are designed to improve patient outcomes and reduce complications in medical treatments. Nanexa is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanexa stock

Intangible Assets of Nanexa is 59.40 M SEK in 2024.

Intangible Assets of Nanexa changed from 40.48 M SEK to 59.40 M SEK, representing a 46.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Nanexa since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Nanexa historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Nanexa

All Key Metrics — Nanexa